![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 12, 2017 7:39:37 PM
https://staticseekingalpha1.a.ssl.fastly.net/uploads/sa_presentations/300/4300/slides/26.jpg?1484237754
This is the first time they have listed partnership as part of 12 month milestones. They've mentioned partnerships before but in other contexts, maybe under strategy, but never under 12 month milestones. What's also worthy of noting is partnership(s) for "melanoma and solid tumor indications." If these are going to be with one big pharma (MRK), I believe we can expect a decent deal amount. My bet is on NSCLC.
Given patient enrollment for melanoma registration trial is expected to start in Q2 2017, I expect the long-awaited partnership to be announced this quarter.
As for TRACE, as hschlauch has written about it, and as Punit also said during yesterday's presentation, it seems ready to be used for combinations beyond anti-PD1 agents. Will be exciting to find out who their collaborators are going to be on this one. If I had to guess, KU Leuven and a big pharma will team up on something.
Looking forward to these inflection points this year.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM